Status:
COMPLETED
Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 2
Lead Sponsor:
University of Aarhus
Conditions:
Angina Pectoris
Atherosclerosis
Eligibility:
All Genders
30+ years
Brief Summary
In a cohort of symptomatic patients referred to coronary computed tomography angiography (CCTA), the investigators aim: 1. To investigate and compare the diagnostic precision of Rubidium Positron Emi...
Detailed Description
CCTA has become the preferred diagnostic modality for symptomatic patients with low to intermediate risk of CAD. Of the patients examined, CCTA exclude cardiovascular disease in 70-80% with an excelle...
Eligibility Criteria
Inclusion
- Patients with an indication for CCTA.
- Qualified patients who have signed a written informed consent form.
Exclusion
- CADScor specific
- Fragile or compromised skin in the area for application of the CADScor®Patch.
- Known allergy to polyacrylate adhesives.
- Significant operation scars or abnormal body shape in left IC4 (4th Inter Costal region).
- Use of vasodilating agents at the same day and prior to CAD-score measurements.
- Demography and co-existing cardiac morbidity specific
- Age below 30 years.
- Patients having a donor heart, a mechanic heart, or mechanical heart pump.
- Suspicion acute coronary syndrome Previous revascularization.
- Scan specific
- CCTA:
- Pregnant women, including women who are potentially pregnant or lactating.
- Reduced kidney function, with an estimated glomerular filtration rate (eGFR) \< 40 mL/min.
- Allergy to X-ray contrast medium.
- CMRI and PET:
- Contra-indication for adenosine (severe asthma, advanced AV block, or critical aorta stenosis).
- Contra-indications for MRI (implanted medicinal pumps or nerve stimulators, magnetic foreign objects in sensitive areas, i.e. the eye).
- Patients having an ICD or pacemaker, a cochlea implant, or metal clips evaluated by the including doctor.
- General:
- \- Patients not able to breath-hold (COPD/asthma).
Key Trial Info
Start Date :
January 24 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 3 2020
Estimated Enrollment :
1732 Patients enrolled
Trial Details
Trial ID
NCT03481712
Start Date
January 24 2018
End Date
December 3 2020
Last Update
January 20 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Central Jutland, Denmark, 8200
2
Regional Hospital of Herning
Herning, Central Jutland, Denmark, 7400
3
Regional Hospital of Silkeborg
Silkeborg, Central Jutland, Denmark, 8600
4
Regional Hospital of Randers
Randers, Denmark, 8900